Oct 25, 2019 | Clinical Outcomes, Special Populations
Harry E. Sarles – DHAT Research Institute, Richardson, TX Annette E. Whitney – Digestive Health Associates of Texas, Dallas, TX Lucinda J. Van Anglen – Healix Infusion Therapy, Sugar Land, TX Samantha A. Kuten – Healix Infusion Therapy, Sugar...Oct 25, 2019 | Clinical Outcomes, Cost Savings
Harry E. Sarles – DHAT Research Institute, Richardson, TX Thomas C. Hardin – Healix Infusion Therapy, Sugar Land, TX Samantha A. Kuten – Healix Infusion Therapy, Sugar Land, TX Lucinda J. Van Anglen – Healix Infusion Therapy, Sugar Land, TX...Oct 2, 2019 | Clinical Outcomes, Cost Savings
Quyen Luu – Central Georgia Infectious Diseases, Macon, GA H. Barry Baker – Infectious Disease Physicians, Miami, FL Ramesh V. Nathan – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA Richard L. Hengel – Atlanta ID Group, Atlanta, GA...Oct 2, 2019 | Clinical Outcomes
John S. Adams – Knoxville Infectious Disease Consultants, Knoxville, TN Brian S. Metzger – Austin Infectious Disease Consultants, Austin, TX Richard M. Mandel – Southern Arizona Infectious Disease Specialists, Tucson, AZ Thomas K. Sleweon –...Oct 2, 2019 | Clinical Outcomes
Richard C. Prokesch – Infectious Disease Associates, Riverdale, GA Claudia P. Schroeder – Healix Infusion Therapy, Sugar Land, TX Thomas C. Hardin – Infectious Disease Associates, Riverdale, GA Lucinda J. Van Anglen – Healix Infusion Therapy,... 
Oct 5, 2018 | Clinical Outcomes
Authors: Timothy E. Ritter, MD – Texas Digestive Disease Consultants, PA, Southlake, TX Chris Fourment, MD – Texas Digestive Disease Consultants, PA, Southlake, TX Bitaal Sadiq, BS – Texas Digestive Disease Consultants, PA, Southlake, TX Claudia P....
Recent Comments